129 related articles for article (PubMed ID: 38881078)
1. Effect of α-blockers on Handgrip Test Response of Diastolic Blood Pressure in Hypertensive, Benign Hypertrophy of Prostate Patients in a Therapeutics Clinic, Kolkata: A Cross-sectional Study.
Samajdar SS; Mukherjee S; Gupta S; Saha D; Kayal A; Begum SA; Chatterjee N; Tripathi SK; Pal J; Joshi SR
J Assoc Physicians India; 2024 Apr; 72(4):21-23. PubMed ID: 38881078
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia.
Tsujii T
Int J Urol; 2000 Jun; 7(6):199-205. PubMed ID: 10843450
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).
Guthrie RM; Siegel RL
Clin Ther; 1999 Oct; 21(10):1732-48. PubMed ID: 10566569
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the Pharmacodynamic Uroselectivity of
Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
[TBL] [Abstract][Full Text] [Related]
5. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
Seo KK; Lee MY; Lim SW; Kim SC
J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses.
Lee E; Lee C
Br J Urol; 1997 Oct; 80(4):606-11. PubMed ID: 9352700
[TBL] [Abstract][Full Text] [Related]
8. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect.
Lowe FC
Clin Ther; 1997; 19(4):730-42. PubMed ID: 9377617
[TBL] [Abstract][Full Text] [Related]
10. Enhanced blood pressure response to isometric handgrip exercise in patients with essential hypertension: effects of propranolol and prazosin.
Hamada M; Kazatani Y; Shigematsu Y; Ito T; Kokubu T; Ishise S
J Hypertens; 1987 Jun; 5(3):305-9. PubMed ID: 3302040
[TBL] [Abstract][Full Text] [Related]
11. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.
Kirby RS
Br J Urol; 1998 Sep; 82(3):373-9. PubMed ID: 9772873
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
13. A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.
Manjunatha R; Pundarikaksha HP; Madhusudhana HR; Amarkumar J; Hanumantharaju BK
Indian J Pharmacol; 2016; 48(2):134-40. PubMed ID: 27127315
[TBL] [Abstract][Full Text] [Related]
14. Interaction of alcohol and an alpha1-blocker on ambulatory blood pressure in patients with essential hypertension.
Kawano Y; Abe H; Kojima S; Takishita S; Omae T
Am J Hypertens; 2000 Mar; 13(3):307-12. PubMed ID: 10777036
[TBL] [Abstract][Full Text] [Related]
15. Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
Lee SH; Park KK; Mah SY; Chung BH
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):333-7. PubMed ID: 20567256
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
17. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
18. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
Yamada S; Ohkura T; Kimura R; Kawabe K
Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients.
Okada H; Kamidono S; Yoshioka T; Okuyama A; Ozono S; Hirao Y; Okajima E; Yamamoto K; Kishimoto T; Park Y; Kurita T
BJU Int; 2000 Apr; 85(6):676-81. PubMed ID: 10759664
[TBL] [Abstract][Full Text] [Related]
20. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]